PETIQ, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.03 USD | +0.63% |
|
-7.39% | -18.84% |
| Mar. 14 | PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs | CI |
| Feb. 28 | Transcript : PetIQ, Inc., Q4 2023 Earnings Call, Feb 28, 2024 |
Financials (USD)
| Sales 2024 * | 1.15B | Sales 2025 * | 1.22B | Capitalization | 468M |
|---|---|---|---|---|---|
| Net income 2024 * | 32M | Net income 2025 * | 42M | EV / Sales 2024 * | 0.41 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.38 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 1,527 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.11% |
More Fundamentals
* Assessed data
More news
Latest transcript on PetIQ, Inc.
More recommendations
More press releases
| 1 day | +0.63% | ||
| 1 week | -7.39% | ||
| Current month | -12.31% | ||
| 1 month | +3.02% | ||
| 3 months | -12.69% | ||
| 6 months | -19.93% | ||
| Current year | -18.84% |
1 week
15.75
16.73
1 month
15.7519.16
Current year
15.0919.74
1 year
11.2622.98
3 years
6.6646.00
5 years
6.6646.00
10 years
6.6646.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 09-12-31 | |
Michael Smith
PSD | President | 46 | 19-06-30 |
Zvi Glasman
DFI | Director of Finance/CFO | 60 | 22-01-02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mark First
BRD | Director/Board Member | 59 | 17-07-25 |
| Director/Board Member | 57 | 21-03-01 | |
| Chief Executive Officer | 51 | 09-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 509 M€ | -.--% | ||
| 0.01% | 9 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 16.03 | +0.63% | 219,622 |
| 24-04-17 | 15.93 | -1.67% | 222,152 |
| 24-04-16 | 16.2 | +0.12% | 282,930 |
| 24-04-15 | 16.18 | -1.70% | 227,978 |
| 24-04-12 | 16.46 | -4.91% | 261,974 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotes
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segmentâs services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Sector
Pharmaceuticals
Calendar
2024-05-07
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16.03
USD
Average target price
29
USD
Spread / Average Target
+80.91%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.84% | 468M | |
| -8.93% | 6.69B | |
| +13.00% | 3.35B | |
| +2.92% | 3.33B | |
| +1.18% | 1.46B | |
| -17.92% | 1.33B | |
| -6.64% | 1.19B | |
| -28.92% | 1.19B | |
| -17.76% | 1.08B | |
| -3.84% | 1.01B |
- Stock Market
- Equities
- PETQ Stock
